Profile data is unavailable for this security.
About the company
Everest Medicines Ltd is a biopharmaceutical company primarily engaged in the discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines. The Company has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The Company conducts its business in the domestic and overseas markets.
- Revenue in HKD (TTM)459.39m
- Net income in HKD-1.16bn
- Incorporated2017
- Employees520.00
- LocationEverest Medicines Ltd16/F., CITIC Pacific Plaza,1168 West Nanjing Road, JingAn DistrictSHANGHAI 200041ChinaCHN
- Websitehttps://www.everestmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Recbio Technology Co Ltd | 0.00 | -602.06m | 4.30bn | 507.00 | -- | 4.64 | -- | -- | -1.26 | -1.26 | 0.00 | 1.92 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Ocumension Therapeutics | 340.57m | -354.21m | 4.40bn | 477.00 | -- | 1.47 | -- | 12.93 | -0.5404 | -0.5404 | 0.5194 | 4.38 | 0.103 | 2.40 | 2.48 | 767,048.60 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -307.25m | 4.98bn | 148.00 | -- | 4.84 | -- | -- | -1.52 | -1.52 | 0.00 | 5.12 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 790.07m | 67.84m | 5.31bn | 777.00 | 74.32 | 3.30 | 36.86 | 6.72 | 0.1332 | 0.1332 | 1.55 | 3.00 | 0.3069 | 1.10 | 2.60 | 971,800.90 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 3.01bn | 918.01m | 6.59bn | 3.18k | 6.85 | 1.62 | 6.56 | 2.19 | 1.14 | 1.14 | 3.73 | 4.81 | 0.5209 | 2.00 | 12.89 | 961,378.10 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.93bn | -41.48m | 6.90bn | 2.65k | -- | 1.42 | -- | 3.58 | -0.0045 | -0.0045 | 0.2075 | 0.5207 | 0.1506 | 0.894 | 3.90 | 670,515.90 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.55bn | 714.29m | 7.15bn | 4.01k | 10.01 | 0.9177 | 5.00 | 0.9468 | 0.5577 | 0.5577 | 5.89 | 6.08 | 0.5026 | 0.9881 | 5.22 | 1,840,563.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 7.43bn | 779.00 | 15.03 | 1.95 | 12.01 | 5.39 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.08bn | 1.81bn | 7.74bn | 4.89k | 4.28 | 0.8142 | 3.69 | 1.27 | 2.06 | 2.06 | 6.91 | 10.81 | 0.4272 | 2.50 | 3.74 | 1,316,787.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 807.84m | 121.46m | 7.82bn | 948.00 | 24.46 | 1.13 | -- | 9.68 | 0.1153 | 0.1153 | 0.7595 | 2.50 | 0.2504 | 1.26 | 1.35 | 852,156.30 | 3.75 | 7.03 | 4.66 | 9.05 | 91.25 | 92.17 | 14.97 | 17.26 | 3.78 | -- | 0.0052 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| China Shineway Pharmaceutical Group Ltd | 4.61bn | 1.21bn | 8.05bn | 3.23k | 6.07 | 1.00 | 5.80 | 1.75 | 1.60 | 1.60 | 6.11 | 9.74 | 0.4476 | 1.28 | 5.26 | 1,343,072.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| AIM Vaccine Co Ltd | 1.30bn | -1.31bn | 8.13bn | 1.56k | -- | 2.11 | -- | 6.25 | -1.08 | -1.08 | 1.07 | 3.18 | 0.1462 | 0.6325 | 1.10 | 800,318.30 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Everest Medicines Ltd | 459.39m | -1.16bn | 8.28bn | 520.00 | -- | 1.69 | -- | 18.02 | -3.59 | -3.59 | 1.42 | 15.09 | 0.0756 | 5.23 | 3.22 | 1,063,409.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Cansino Biologics Inc | 668.99m | -951.24m | 10.69bn | 1.49k | -- | 1.16 | -- | 15.97 | -3.85 | -3.85 | 2.71 | 22.48 | 0.0676 | 1.28 | 0.8385 | 447,782.40 | -10.15 | -4.27 | -13.73 | -5.60 | 14.38 | -- | -150.19 | -27.72 | 2.19 | -- | 0.3028 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Luye Pharma Group Ltd | 6.93bn | 845.64m | 12.30bn | 5.23k | 14.55 | 0.8608 | 7.23 | 1.78 | 0.2248 | 0.2248 | 1.84 | 3.80 | 0.236 | 2.44 | 3.02 | 1,314,909.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Data as of Oct 10 2024. Currency figures normalised to Everest Medicines Ltd's reporting currency: Hong Kong Dollar HKD
14.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Janchor Partners Ltd.as of 30 Sep 2023 | 15.88m | 4.88% |
| RA Capital Management LPas of 23 Nov 2022 | 15.22m | 4.68% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 3.81m | 1.17% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.05m | 0.94% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 2.32m | 0.71% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 2.17m | 0.67% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 1.17m | 0.36% |
| Zhong Geng Fund Management Co. , Ltd.as of 31 Dec 2023 | 1.12m | 0.34% |
| Wellington Management Co. LLPas of 27 Feb 2023 | 678.30k | 0.21% |
| SSgA Funds Management, Inc.as of 03 Jul 2024 | 436.00k | 0.13% |
More ▼
Data from 13 Nov 2023 - 06 Aug 2024Source: FactSet Research Systems Inc.
